Onconova Therapeutics, Inc. to Provide Corporate Update and First Quarter 2017 Financial Results

NEWTOWN, Pa., May 04, 2017 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on Myelodysplastic Syndromes, today announced that Company management will release its first quarter 2017 financial results on May 15, 2017 before the market opens. The Company will host a conference call on May 15th at 9:00 a.m. Eastern Time.